News & Articles

The latest in life sciences from across BioBuzz’s regional hubs.

From Lab to GMP: Industry Leaders Break Down the Operational Realities Behind Scaling Biotech Innovation

BioHealth Capital Region Events

From Lab to GMP: Industry Leaders Break Down the Operational Realities Behind Scaling Biotech Innovation

May 15, 2026

Why Sustainability Is a Business Strategy, Not a Nice-to-Have for AstraZeneca

BioHealth Capital Region Events

Why Sustainability Is a Business Strategy, Not a Nice-to-Have for AstraZeneca

May 14, 2026

Jeeva Clinical Trials Acquires Clintelligence AI to Advance Smarter Clinical Development

BioHealth Capital Region Research Press Release

Jeeva Clinical Trials Acquires Clintelligence AI to Advance Smarter Clinical Development

May 14, 2026

Bora Pharmaceuticals to Acquire MacroGenics Manufacturing Facility in $122.5 Million Deal

BioHealth Capital Region Funding Press Release

Bora Pharmaceuticals to Acquire MacroGenics Manufacturing Facility in $122.5 Million Deal

May 14, 2026

The Other Side of Arcellx’s $7.8 Billion Exit: What the Gilead Buyout Means for Maryland’s Biotech Workforce

BioHealth Capital Region Funding

The Other Side of Arcellx’s $7.8 Billion Exit: What the Gilead Buyout Means for Maryland’s Biotech Workforce

May 13, 2026

In Conversation with Shannon Ryan: Why AI Readiness—not Adoption—is Becoming Biotech’s Real Bottleneck

BioHealth Capital Region People In Conversation

In Conversation with Shannon Ryan: Why AI Readiness—not Adoption—is Becoming Biotech’s Real Bottleneck

May 13, 2026

In Conversation with Preeyam Patel: The Biomarker Challenge Shaping the Next Era of Drug Development

BioHealth Capital Region People In Conversation

In Conversation with Preeyam Patel: The Biomarker Challenge Shaping the Next Era of Drug Development

May 12, 2026

Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Cell and Gene Therapy Development

BioHealth Capital Region Industry Trends Research

Aldevron and Minaris Renew Lentiviral Plasmid Agreement to Accelerate Cell and Gene Therapy Development

May 12, 2026

The Infrastructure Behind Innovation: Why Building Biotech’s Backbone Is Becoming Strategic

BioHealth Capital Region People 5 Questions With

The Infrastructure Behind Innovation: Why Building Biotech’s Backbone Is Becoming Strategic

May 12, 2026

Private Equity’s Next Bet in Cell and Gene Therapy Manufacturing, Rose BioSolutions

BioHealth Capital Region Funding Industry Trends

Private Equity’s Next Bet in Cell and Gene Therapy Manufacturing, Rose BioSolutions

May 11, 2026

Why Northern Virginia’s Newest Innovation District – Nexus234 – is Receiving Global Recognition

BioHealth Capital Region Events In Conversation

Why Northern Virginia’s Newest Innovation District – Nexus234 – is Receiving Global Recognition

May 11, 2026

Moving Faster Toward the Clinic: Inside Biotech’s New Era of IND Readiness

BioHealth Capital Region Events

Moving Faster Toward the Clinic: Inside Biotech’s New Era of IND Readiness

May 8, 2026

Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations

Greater Philadelphia Funding Press Release

Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations

May 5, 2026

A Night of Sharing Successes and Uplifting Women in Life Sciences

BioHealth Capital Region Events

A Night of Sharing Successes and Uplifting Women in Life Sciences

May 5, 2026

Time, Labor, and Giving Back: A Scientist’s Perspective on Volunteering

BioHealth Capital Region People

Time, Labor, and Giving Back: A Scientist’s Perspective on Volunteering

May 4, 2026

Why Global Health Startups Are Entering the U.S. More Prepared Than Ever

Greater Philadelphia Events

Why Global Health Startups Are Entering the U.S. More Prepared Than Ever

May 4, 2026

AstraZeneca’s $2B Bet on Maryland’s Bioeconomy And the Reality of What It Takes to Deliver

BioHealth Capital Region Events

AstraZeneca’s $2B Bet on Maryland’s Bioeconomy And the Reality of What It Takes to Deliver

May 4, 2026

Analytics Now defines speed in Biopharma

Greater Philadelphia People In Conversation

Analytics Now defines speed in Biopharma

May 4, 2026

Analytics Is the New Bottleneck in Gene Therapy

Greater Philadelphia Workforce In Conversation

Analytics Is the New Bottleneck in Gene Therapy

May 4, 2026

TEDCO Invests in ICaPath

BioHealth Capital Region Funding Press Release

TEDCO Invests in ICaPath

April 29, 2026

The Future of Biopharma Depends on What We Choose to Fund

Greater Philadelphia People In Conversation

The Future of Biopharma Depends on What We Choose to Fund

April 29, 2026